Cryo-Cell International, Inc.
CCEL
AMEX·Healthcare·Medical - Care Facilities·Mkt cap $34.5M
$4.28
▲ +0.94%
P/E
53.50
Mkt Cap
$34.5M
52-Wk Range
$2.72–$5.01
52-Week Range
$2.72 - $5.01
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 0.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
2 risks
- Low volatility (beta 0.6).
- Significant premium - growth priced in
Growth
Strong growth ahead
Value
Significant premium - growth priced in
Momentum
Strong
+16.6% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying CCEL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 9, 2026
JUL 15, 2026
Reported EPS of $0.07 vs -$0.02 consensus (+450.0% surprise). Revenue of $7.8M vs $7.6M expected (+3.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+450.0%
Revenue trend · last 2Q
—
—
Q1 26
Q2 26
$7.7M
$0
Margins · last 2Q
Profit
—
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How CCEL stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.